understanding nsclc treatment when you have an egfr mutation
Published 2 months ago • 1K plays • Length 5:03Download video MP4
Download video MP3
Similar videos
-
3:50
what is an egfr mutation for lung cancer?
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
5:41
understanding nsclc treatments for less common mutations: alk, braf, ros1, her2, met
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
37:23
nsclc: integrating egfr-inhibiting therapies into clinical pathways for first-line treatment
-
5:53
targeted therapy in non-small cell lung cancer
-
59:36
ilcn multidisciplinary forum: understanding treatment options and resistance in egfr-positive nsclc
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
1:41
egfr mutations in patients with lung cancer
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
5:52
treatment of egfr nsclc after osimertinib
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
58:47
15 years of advances in egfr mutant lung cancer
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc